Needham Maintains Buy on Doximity, Lowers Price Target to $27

Doximity, Inc. Class A

Doximity, Inc. Class A

DOCS

0.00

Needham analyst Ryan MacDonald maintains Doximity (NYSE: DOCS) with a Buy and lowers the price target from $55 to $27.